课题基金 / 基金详情

Mechanisms of vasodilation by K^+ channel openers

Mechanisms of vasodilation by K^+ channel openers
K^通道开放剂的血管舒张机制
批准号:
02670076
负责人:
YANAGISAWA Teruyuki
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1991

项目摘要

项目成果

YANAGISAWA Teruyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To investigate the vasodilator mechanisms of the K^+ channel openers, cromakalim, pinacidil and nicorandil, we measured changes in cytoplasmic Ca^<2+> concentration ([Ca^<2+>]i) simultaneously with force by a microfluorimetric method using fura-2. Cromakalim is a more specific K^+ channel opener than pinacidil and nicorandil and that vasodilation produced by cromakalim in this study is predominantly a result of a reduction of[Ca^<2+>]i due to the closure of voltage-dependent Ca^<2+> channels by hyperpolarization. In contrast, additional mechanisms are involved in the vasodilator actions of pinacidil and nicorandil. One of these is related to a reduction in the sensitivity of contractile proteins to Ca^<2+>. The latter mechanism of nicorandil is akin to that of nitroglycerin. K^+ channels opened by these K^+ channel openers may be ATP-sensitive ones which are blocked by glibenclamide. A thromboxane A2 analogue U46619 increased [Ca^<2+>]i and force, upon cumulative application in canine … More coronary arteries. Depolarization by 20 mM KCI potentiated the increases in [Ca^<2+>]i and force induced by U46619. Cromakalim and verapamil inhibited both increases. The inhibitory effect of cromakalim was counteracted by depolarization by 20 or 25 mM KCI. Upon single dose applications of U46619 at 3x10^<-7> M, [Ca^<2+>]i and force increased in phasic and tonic manners, which were almost abolished by cromakalim and Ki4032. In the absence of extracellular Ca^<2+>, U46619 induced a transient increase in [Ca^<2+>]i with a contraction. In the presence of cromakalim or Ki4032, the increase in[Ca^<2+>]i was abolished, which was blocked by the K^+ channel blocker tetrabutylammonium(TBA)and counteracted by the depolarization by 20 mM KCI. Cromakalim and Ki4032 did not affect caffeine-induced Ca^<2+> release. Thus, U46619 produces Ca^<2+> influx through L-type Ca^<2+> channels, which are deactivated by hyperpolarization induced by cromakalim and Ki4032. The IP_3-induced Ca^<2+> release from intracellular stores related to stimulation of the thromboxane A^2 receptor is selectively inhibited by hyperpolarization of plasma membrane by K^+ channel openers. Less
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
柳澤 輝行: "血管平滑筋のKチャンネルとそのモジュレ-タ-" 心臓. 24. 215-221 (1992)
Teruyuki Yanagisawa:“血管平滑肌 K 通道及其调节剂”《心脏》24. 215-221 (1992)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
29
    Attempt of Cancer Pain Control with the aid of Anti-TRPV Channel Antibody
    • 批准号:
      18613001
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.61万
    • 财政年份:
      2006
    • 负责人:
      YANAGISAWA Teruyuki
    • 依托单位:
    Molecular and Applied Pharmacology of Subunits of Ion Channels as Biosensors
    • 批准号:
      10559002
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $8.38万
    • 财政年份:
      1998
    • 负责人:
      YANAGISAWA Teruyuki
    • 依托单位:
    Molecular Pharmacology of Selective beta3-Adrenergic Receptors
    • 批准号:
      07557327
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $3.97万
    • 财政年份:
      1995
    • 负责人:
      YANAGISAWA Teruyuki
    • 依托单位:
    Cellular Pharmacology of Hyperpolarization-Relaxation Coupling
    • 批准号:
      07457020
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.74万
    • 财政年份:
      1995
    • 负责人:
      YANAGISAWA Teruyuki
    • 依托单位:
    海外基金